In-Depth Overview of Site-Specific Conjugation Technologies in ADC Development
mybcs
Traditional ADCs: The Need for Precision Over the past decade, all FDA-approved antibody-drug conjugates (ADCs) have been heterogeneous mixtures composed of monoclonal antibodies (mAbs) conjugated with varying numbers of cytotoxic drugs […]